| Effect of an Antiseptic Solution on the Skin Microbiome (NCT05608382) | Center for Innovation and Research Organization | 2022-03-07 |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts (NCT03981822) | Verrica Pharmaceuticals Inc. | 2019-06-25 |
| Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) (NCT03643952) | Merck Sharp & Dohme LLC | 2018-12-06 |
| Cantharidin and Occlusion in Verruca Epithelium (NCT03487549) | Verrica Pharmaceuticals Inc. | 2018-03-27 |
| Skin and Soft Tissue Infection (SSTI) Study (NCT02600871) | The University of Texas Health Science Center at San Antonio | 2015-12-01 |
| Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012) (NCT02276482) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-03-25 |
| Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA (NCT02582203) | Wayne State University | 2012-02-01 |
| Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections (NCT00990392) | Fraser Health | 2009-11-01 |
| Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) (NCT00865280) | Paratek Pharmaceuticals Inc | 2009-04-04 |
| MRSA Colonization and Control in the Dallas County Jail (NCT00785200) | University of Chicago | 2009-01-01 |
| Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections (NCT00761215) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2008-09-17 |
| Study of Wound Packing After Superficial Skin Abscess Drainage (NCT00746109) | NYU Langone Health | 2008-09-01 |
| Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections (NCT00711802) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2008-07-23 |
| Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age (NCT00488345) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-12-01 |
| Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI (NCT00488761) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-07-01 |
| Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections (NCT00430937) | Novartis Pharmaceuticals | 2006-04-01 |
| Effective Antibiotic Treatment of MRSA (NCT00388310) | Christiana Care Health Services | 2006-02-01 |
| Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections (NCT00210899) | Basilea Pharmaceutica | 2005-09-01 |
| AUGMENTIN 1gm In Skin And Soft Tissue Infection (NCT00343135) | GlaxoSmithKline | 2004-12-01 |
| Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections (NCT00228982) | Basilea Pharmaceutica | 2004-10-01 |
| Effect of Chlorhexidine Skin Cleansing on Skin Flora (NCT00198679) | Johns Hopkins Bloomberg School of Public Health | 2004-03-01 |
| Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections (NCT00228410) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-11-01 |
| A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin (NCT00257062) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1993-01-01 |
| A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin (NCT00257036) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1991-07-01 |